Literature DB >> 26214150

Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.

Auriel A Willette1, Barbara B Bendlin2, Erika J Starks3, Alex C Birdsill3, Sterling C Johnson4, Bradley T Christian5, Ozioma C Okonkwo2, Asenath La Rue6, Bruce P Hermann6, Rebecca L Koscik6, Erin M Jonaitis6, Mark A Sager6, Sanjay Asthana7.   

Abstract

IMPORTANCE: Converging evidence suggests that Alzheimer disease (AD) involves insulin signaling impairment. Patients with AD and individuals at risk for AD show reduced glucose metabolism, as indexed by fludeoxyglucose F 18-labeled positron emission tomography (FDG-PET).
OBJECTIVES: To determine whether insulin resistance predicts AD-like global and regional glucose metabolism deficits in late middle-aged participants at risk for AD and to examine whether insulin resistance-predicted variation in regional glucose metabolism is associated with worse cognitive performance. DESIGN, SETTING, AND PARTICIPANTS: This population-based, cross-sectional study included 150 cognitively normal, late middle-aged (mean [SD] age, 60.7 [5.8] years) adults from the Wisconsin Registry for Alzheimer's Prevention (WRAP) study, a general community sample enriched for AD parental history. Participants underwent cognitive testing, fasting blood draw, and FDG-PET at baseline. We used the homeostatic model assessment of peripheral insulin resistance (HOMA-IR). Regression analysis tested the statistical effect of HOMA-IR on global glucose metabolism. We used a voxelwise analysis to determine whether HOMA-IR predicted regional glucose metabolism. Finally, predicted variation in regional glucose metabolism was regressed against cognitive factors. Covariates included age, sex, body mass index, apolipoprotein E ε4 genotype, AD parental history status, and a reference region used to normalize regional uptake. MAIN OUTCOMES AND MEASURES: Regional glucose uptake determined using FDG-PET and neuropsychological factors.
RESULTS: Higher HOMA-IR was associated with lower global glucose metabolism (β = -0.29; P < .01) and lower regional glucose metabolism across large portions of the frontal, lateral parietal, lateral temporal, and medial temporal lobes (P < .05, familywise error corrected). The association was especially robust in the left medial temporal lobe (R2 = 0.178). Lower glucose metabolism in the left medial temporal lobe predicted by HOMA-IR was significantly related to worse performance on the immediate memory (β = 0.317; t148 = 4.08; P < .001) and delayed memory (β = 0.305; t148 = 3.895; P < .001) factor scores. CONCLUSIONS AND RELEVANCE: Our results show that insulin resistance, a prevalent and increasingly common condition in developed countries, is associated with significantly lower regional cerebral glucose metabolism, which in turn may predict worse memory performance. Midlife may be a critical period for initiating treatments to lower peripheral insulin resistance to maintain neural metabolism and cognitive function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26214150      PMCID: PMC4570876          DOI: 10.1001/jamaneurol.2015.0613

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  63 in total

1.  Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.

Authors:  Eric M Reiman; Kewei Chen; Gene E Alexander; Richard J Caselli; Daniel Bandy; David Osborne; Ann M Saunders; John Hardy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

2.  Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization.

Authors:  Per Borghammer; Joel Aanerud; Albert Gjedde
Journal:  Neuroimage       Date:  2009-03-19       Impact factor: 6.556

Review 3.  Insulin and Alzheimer's disease: untangling the web.

Authors:  Suzanne Craft; Brenna Cholerton; Laura D Baker
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

Authors:  G D Rabinovici; H J Rosen; A Alkalay; J Kornak; A J Furst; N Agarwal; E C Mormino; J P O'Neil; M Janabi; A Karydas; M E Growdon; J Y Jang; E J Huang; S J Dearmond; J Q Trojanowski; L T Grinberg; M L Gorno-Tempini; W W Seeley; B L Miller; W J Jagust
Journal:  Neurology       Date:  2011-11-30       Impact factor: 9.910

5.  Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.

Authors:  Amy Claxton; Laura D Baker; Angela Hanson; Emily H Trittschuh; Brenna Cholerton; Amy Morgan; Maureen Callaghan; Matthew Arbuckle; Colin Behl; Suzanne Craft
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

6.  Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions.

Authors:  Christine M Burns; Kewei Chen; Alfred W Kaszniak; Wendy Lee; Gene E Alexander; Daniel Bandy; Adam S Fleisher; Richard J Caselli; Eric M Reiman
Journal:  Neurology       Date:  2013-03-27       Impact factor: 9.910

7.  Glucose levels and risk of dementia.

Authors:  Paul K Crane; Rod Walker; Rebecca A Hubbard; Ge Li; David M Nathan; Hui Zheng; Sebastien Haneuse; Suzanne Craft; Thomas J Montine; Steven E Kahn; Wayne McCormick; Susan M McCurry; James D Bowen; Eric B Larson
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245

8.  Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study.

Authors:  Zaldy S Tan; Alexa S Beiser; Caroline S Fox; Rhoda Au; Jayandra J Himali; Stephanie Debette; Charles Decarli; Ramachandran S Vasan; Philip A Wolf; Sudha Seshadri
Journal:  Diabetes Care       Date:  2011-06-16       Impact factor: 19.112

9.  Reference cluster normalization improves detection of frontotemporal lobar degeneration by means of FDG-PET.

Authors:  Juergen Dukart; Robert Perneczky; Stefan Förster; Henryk Barthel; Janine Diehl-Schmid; Bogdan Draganski; Hellmuth Obrig; Emiliano Santarnecchi; Alexander Drzezga; Andreas Fellgiebel; Richard Frackowiak; Alexander Kurz; Karsten Müller; Osama Sabri; Matthias L Schroeter; Igor Yakushev
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study.

Authors:  Weili Xu; Chengxuan Qiu; Margaret Gatz; Nancy L Pedersen; Boo Johansson; Laura Fratiglioni
Journal:  Diabetes       Date:  2008-10-24       Impact factor: 9.461

View more
  115 in total

1.  Calorie restriction leads to greater Akt2 activity and glucose uptake by insulin-stimulated skeletal muscle from old rats.

Authors:  Haiyan Wang; Edward B Arias; Gregory D Cartee
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-06       Impact factor: 3.619

Review 2.  Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease.

Authors:  Md Sahab Uddin; Dewan Md Sumsuzzman; Philippe Jeandet; Tapan Behl; Abdur Rauf; Md Shah Amran; Ghulam Md Ashraf
Journal:  Neurochem Res       Date:  2021-04-19       Impact factor: 3.996

3.  Cholecystokinin and Alzheimer's disease: a biomarker of metabolic function, neural integrity, and cognitive performance.

Authors:  Alexandra Plagman; Siobhan Hoscheidt; Kelsey E McLimans; Brandon Klinedinst; Colleen Pappas; Vellareddy Anantharam; Anumantha Kanthasamy; Auriel A Willette
Journal:  Neurobiol Aging       Date:  2019-01-09       Impact factor: 4.673

4.  Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease.

Authors:  Roger J Mullins; Maja Mustapic; Edward J Goetzl; Dimitrios Kapogiannis
Journal:  Hum Brain Mapp       Date:  2017-01-20       Impact factor: 5.038

5.  Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.

Authors:  Kelsey E McLimans; Auriel A Willette
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Alterations in neuronal metabolism contribute to the pathogenesis of prion disease.

Authors:  Julie-Myrtille Bourgognon; Jereme G Spiers; Hannah Scheiblich; Alexey Antonov; Sophie J Bradley; Andrew B Tobin; Joern R Steinert
Journal:  Cell Death Differ       Date:  2018-06-18       Impact factor: 15.828

7.  Type 2 diabetes and later cognitive function in older American Indians: The Strong Heart Study.

Authors:  Brenna Cholerton; Adam Omidpanah; Steven P Verney; Lonnie A Nelson; Laura D Baker; Astrid Suchy-Dicey; William T Longstreth; Barbara V Howard; Jeffrey A Henderson; Thomas J Montine; Dedra Buchwald
Journal:  Int J Geriatr Psychiatry       Date:  2019-04-15       Impact factor: 3.485

8.  Brain insulin resistance and altered brain glucose are related to memory impairments in schizophrenia.

Authors:  S Andrea Wijtenburg; Dimitrios Kapogiannis; Stephanie A Korenic; Roger J Mullins; Joyce Tran; Frank E Gaston; Shuo Chen; Maja Mustapic; L Elliot Hong; Laura M Rowland
Journal:  Schizophr Res       Date:  2019-02-11       Impact factor: 4.939

Review 9.  Targeting acidity in cancer and diabetes.

Authors:  Robert J Gillies; Christian Pilot; Yoshinori Marunaka; Stefano Fais
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-01-30       Impact factor: 10.680

Review 10.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.